Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | Using WGS and transcriptome sequencing to improve prognostic classification in T-ALL

Petri Pölönen • 9 Jun 2022
EHA 2022
Acute Lymphoblastic Leukemia Leukemia Rare Diseases

Petri Pölönen, PhD, St. Jude’s Research Hospital, Memphis, TN, briefly explains the need to improve diagnostic tools in T-cell acute lymphoblastic leukemia (T-ALL), highlighting the importance of using whole genome sequencing (WGS) and transcriptome sequencing to obtain genomic information.This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Petri Pölönen

2:57
Genome characterization of T-ALL patients
Petri Pölönen • 9 Jun 2022

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals